Media Centre and News

Milestones

  • Until July 2025, our company has 18 products approved for market launch, including two imported registered products.
  • Since 2023, multiple products such as Atorvastatin Calcium Tablets, Losartan Potassium Tablets, Valsartan Tablets and Gliclazide Modified Release Tablets won bidding in multiple provincial tenders.
  • January 2021: Pregabalin capsules were awarded in 4th national tender
  • December 2020: Obtained marketing authorisation for Pregabalin capsules.
  • November 2020: Obtained Pharmaceutical Production License.
  • September 2018: Support in attaining EU GMP certification for first contract manufacturing facility. First sales of finished pharmaceutical products in the EU.
  • June 2018: Technology transfer for the first product (pregabalin capsules) and production validation completed.

Phone


HR department:
Tracy Wang 0574-87916641-8007

Commercial department:
Lisa Qiu 0574-87916641

Financial department:
Frances Fang 0574-87916641-8002

Pharmacovigilance:
(+86)-18067174428